Media & Resources

IAVI Ranks among Top One Percent of Charities Nationwide NEW YORK, October 29, 2008 – For the seventh consecutive year, the International AIDS Vaccine Initiative (IAVI) has received a four-star rating from Charity Navigator, America’s largest independent evaluator of charities.  This rating indicates that IAVI, the world’s only nonprofit organization dedicated solely to AIDS vaccine…

IAVI awards innovation grant to South African biotech company for the development and testing of new vaccine antigens that elicit broadly neutralizing antibodies against HIV JOHANNESBURG, October 10, 2008 – Elevation Biotech, a start-up biotechnology company funded by LIFElab, an agency of the South African Department of Science and Technology, and the International AIDS Vaccine…

Goal is to solve the number one scientific problem impeding AIDS vaccine development LA JOLLA, CA, and NEW YORK, NY, September 30, 2008 — The Scripps Research Institute, one of the world’s largest independent, non-profit biomedical research organizations, and the International AIDS Vaccine Initiative (IAVI), the world’s only global non-profit organization focused solely on AIDS…

India Continues to Progress in AIDS Vaccine Development Efforts Phase I clinical trial of a preventive vaccine shows encouraging outcome Chennai, August 16, 2008 – A second Phase I AIDS vaccine clinical trial in India was successfully completed, the Indian Council of Medical Research, the National AIDS Control Organization and the International AIDS Vaccine Initiative…

DNA Vaccine Delivery Technology Shows Promise in Inducing Stronger Immune Responses SAN DIEGO, August 14, 2008—Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using a proprietary electroporation-based DNA delivery platform, announced today it has expanded its research license with the International AIDS Vaccine Initiative (IAVI), a leading organization dedicated to…

MEXICO CITY, XVII International AIDS Conference, August 7, 2008 – Discussions about how to manage AIDS in the long term and how to improve prevention efforts globally took center stage at this year’s International AIDS Conference (IAC) held in Mexico City. Unlike previous IAC conferences, this year’s event did not have a plenary session focused…

Resetting Expectations in the Search for an AIDS Vaccine In its AIDS Vaccine Blueprint 2008, IAVI proposes a series of interim milestones to help overcome the biggest challenges facing the AIDS vaccine field today MEXICO CITY, August 5, 2008 – With the release of its AIDS Vaccine Blueprint 2008 at the International AIDS Conference today…

Calls for Sustained Funding to Maintain HIV Prevention Research Efforts Mexico City, August 5, 2008 – A new report released today shows that funding for biomedical HIV prevention research and development (R&D), including AIDS vaccines and microbicides, increased dramatically between 2000 and 2006 with only a modest increase in 2007. The report warns that the…